Global Stem Cell Therapy Market 2017-2021

Publisher Name :
Date: 25-Jan-2017
No. of pages: 70
Price : Single User: US $ 3500  US $ 2500 Corporate User: US $ 5000  US $ 4000
Inquire Before Buying
Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

The analysts forecast the global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global stem cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of stem cell therapy products/segments in the market.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • Holostem Advanced Therapies

  • JCR Pharmaceuticals

  • Organogenesis

  • Osiris Therapeutics

  • Vericel


Other prominent vendors


  • AbbVie

  • American CryoStem

  • AM-Pharma

  • Anterogen

  • apceth Biopharma

  • Astellas Pharma

  • Athersys

  • Baxter International

  • Beike Biotechnology

  • BIOTIME

  • bluebird bio

  • Bristol-Myers Squibb

  • BrainStorm Cell Therapeutics

  • Brainxell

  • Caladrius Biosciences

  • Cellular Biomedicine Group

  • Cellular Dynamics International (a subsidiary of Fujifilm)

  • Cesca Therapeutics

  • CHA Biotech

  • Chugai Pharmaceutical

  • Citospin

  • Corestem

  • Cytori Therapeutics

  • Daiichi Sankyo

  • Fujifilm

  • Gamida Cell

  • Global Stem Cells Group

  • Grupo Ferrer Internacional

  • GlaxoSmithKline

  • Hemostemix

  • Histocell

  • International Stem Cell

  • Ivy Institute of Stem Cells

  • Japan Regenerative Medicine

  • Kangstem Biotech

  • Kiadis Pharma

  • Laboratorios Salvat

  • MEDIPOST

  • Mesoblast

  • Nuo Therapeutics

  • Opsis Therapeutics

  • Osiris Therapeutics

  • Pharmicell

  • Pluristem Therapeutics

  • Promethera Biosciences

  • Q Therapeutics

  • ReNeuron

  • RHEACELL

  • Salus Medical Solutions

  • Sangamo Therapeutics

  • Shire

  • Steminent Biotherapeutics

  • Sumitomo Dainippon Pharma

  • Taiwan Bio Therapeutics

  • Takeda Pharmaceutical

  • Teva Pharmaceutical Industries

  • Thoratec Corporation

  • TiGenix

  • Translational Biosciences

  • TWO CELLS

  • U.S. Stem Cell

  • ViaCyte

  • VistaGen Therapeutics


Market driver


  • Increase in federal funding in stem cell therapy

  • For a full, detailed list, view our report


Market challenge


  • Stringent regulatory environment affecting the product approvals

  • For a full, detailed list, view our report


Market trend


  • Evolution of new destinations in the development of stem cell therapies

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Stem Cell Therapy Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Key market highlights

PART 05: Understanding of stem cell therapy
History of stem cell research

PART 06: Ethical issues and regulatory landscape
Ethical issues of stem cell research at different phases of research

PART 07: Key clinical trials
Attractive clinical trial locations to invest
Commercially attractive therapy areas to invest

PART 08: Market landscape
Market overview
Five forces analysis

PART 09: Market segmentation by therapy
Allogeneic stem cell therapy
Autologous stem cell therapy

PART 10: Market segmentation by applications
Dermatology
Musculoskeletal
Cardiovascular

PART 11: Geographical segmentation
Stem cell therapy market in Americas
Stem cell therapy market in EMEA
Stem cell therapy market in APAC

PART 12: Market drivers
Limitations in traditional organ transplantations fueling the demand for stem cell therapies
Increase in federal funding in stem cell therapy
Growing demand for personalized medicine
Increasing demand to develop effective drugs for cardiology and degenerative disorders

PART 13: Impact of drivers

PART 14: Market challenges
Stringent regulatory environment affecting the product approvals
Critical ethical challenges with respect to stem cell research
High cost of clinical trials and failure rate in clinical trials

PART 15: Impact of drivers and challenges

PART 16: Market trends
Evolution of new destinations in the development of stem cell therapies
Increasing inorganic growth strategies such as acquisitions and licensing agreements
Growing focus on the development of drugs for emerging applications
Increasing investments from private enterprises likely to fuel market growth

PART 17: Vendor landscape
Competitive scenario

PART 18: Key vendor analysis
Holostem Advanced Therapies
JCR Pharmaceuticals
Organogenesis
Osiris Therapeutics
Vericel1
Other prominent vendors4

PART 19: Appendix7
List of abbreviations7

List of Exhibits

Exhibit 01: Developments in stem cell research
Exhibit 02: Ethical issues faced by various institutes at different phases of cell therapy research
Exhibit 03: Stem cell research policies in Americas
Exhibit 04: Stem cell research policies in EMEA
Exhibit 05: Stem cell research policies in APAC
Exhibit 06: Historical trend of pipeline candidates in different phases
Exhibit 07: Snapshot of pipeline trends in stem cell therapy market
Exhibit 08: Pipeline landscape by therapeutic area 2016
Exhibit 09: Pipeline by development phase 2016
Exhibit 10: Pipeline snapshot in key therapy areas
Exhibit 11: Brief overview of attractive clinical trial locations, therapy areas, and cell types
Exhibit 12: Key clinical trials
Exhibit 13: Global stem cell therapy market snapshot
Exhibit 14: Key marketed products and their company
Exhibit 15: Key vendors with robust Phase III pipeline
Exhibit 16: Global stem cell therapy market 2016-2021 ($ millions)
Exhibit 17: Opportunity analysis in global stem cell therapy market
Exhibit 18: Five forces analysis
Exhibit 19: Global stem cell therapy market segmentation by therapy 2016
Exhibit 20: Global allogeneic stem cell therapy market 2016-2021 ($ millions)
Exhibit 21: Opportunity analysis of allogeneic stem cell therapy market
Exhibit 22: Global autologous stem cell therapy market 2016-2021 ($ millions)
Exhibit 23: Opportunity analysis of autologous stem cell therapy market
Exhibit 24: Global stem cell therapy market segmentation by application 2016
Exhibit 25: Overview of dermatology in stem cell therapy market
Exhibit 26: Overview of musculoskeletal in regenerative medicine market
Exhibit 27: Overview of cardiovascular in stem cell therapy market
Exhibit 28: Segmentation of global stem cell therapy market based on geography 2016 and 2021
Exhibit 29: Stem cell therapy market revenue by geography 2016-2021 ($ millions)
Exhibit 30: Market scenario in Americas
Exhibit 31: Stem cell therapy market in Americas ($ millions)
Exhibit 32: Market scenario in EMEA
Exhibit 33: Stem cell therapy market in EMEA ($ millions)
Exhibit 34: Market scenario in APAC
Exhibit 35: Stem cell therapy market in APAC ($ millions)
Exhibit 36: Key stem cell therapy market developments in Japan by global vendors 2015
Exhibit 37: NIH: YoY and growth rate of spending toward stem cell research ($ billions)
Exhibit 38: Breakdown of CIRM funding in various stem cell research funding in 2014 ($ billions)
Exhibit 39: Active programs under CIRM 2014
Exhibit 40: Details of EC funding
Exhibit 41: Impact of drivers
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Regulatory guidelines in Japan
Exhibit 44: Key inorganic growth strategies in global stem cell therapy market
Exhibit 45: Competitive structure analysis of global stem cell therapy market 2016
Exhibit 46: Competitive analysis of global stem cell therapy market
Exhibit 47: Some of the key approvals in global stem cell therapy
Exhibit 48: Strategic success factors of companies in global stem cell therapy market
Exhibit 49: Holostem Advanced Therapies: Key highlights
Exhibit 50: Holostem Advanced Therapies: Strength assessment
Exhibit 51: Holostem Advanced Therapies: Strategy assessment
Exhibit 52: Holostem Advanced Therapies: Opportunity assessment
Exhibit 53: JCR Pharmaceuticals: Strength assessment
Exhibit 54: JCR Pharmaceuticals: Strategy assessment
Exhibit 55: JCR Pharmaceuticals: Opportunity assessment
Exhibit 56: Organogenesis: Key highlights
Exhibit 57: Organogenesis: Strength assessment
Exhibit 58: Organogenesis: Strategy assessment
Exhibit 59: Organogenesis: Opportunity assessment
Exhibit 60: Osiris Therapeutics: Key highlights
Exhibit 61: Osiris Therapeutics: Strength assessment
Exhibit 62: Osiris Therapeutics: Strategy assessment
Exhibit 63: Osiris Therapeutics: Opportunity assessment
Exhibit 64: Vericel: Key highlights
Exhibit 65: Vericel: Strength assessment
Exhibit 66: Vericel: Strategy assessment
Exhibit 67: Vericel: Opportunity assessment

  • 2017 Top 5 Mesenchymal Stem Cells Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 18-Aug-2017        Price: US 4960 Onwards        Pages: 167
    "This report will be delivered in 2-3 business days after the order is placed."The Global Mesenchymal Stem Cells market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.This report studies Mesenchymal Stem Cells in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Mesenchymal Stem Cells Players in each region, ......
  • 2017-2022 China Mesenchymal Stem Cells Market Report (Status and Outlook)
    Published: 18-Aug-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed."The Mesenchymal Stem Cells market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In China market, the top players include Lonza Thermo Fisher Bio-Techne Miltenyi Biotec PromoCell GmbH Irvine Scientific ......
  • 2017-2022 Global Top Countries Mesenchymal Stem Cells Market Report
    Published: 18-Aug-2017        Price: US 4960 Onwards        Pages: 167
    "This report will be delivered in 2-3 business days after the order is placed."The Global Mesenchymal Stem Cells market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.This report studies Mesenchymal Stem Cells in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East an......
  • 2017-2022 India Mesenchymal Stem Cells Market Report (Status and Outlook)
    Published: 18-Aug-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed."The Mesenchymal Stem Cells market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In India market, the top players include Lonza Thermo Fisher Bio-Techne Miltenyi Biotec PromoCell GmbH Irvine Scientific ......
  • 2017-2022 Japan Mesenchymal Stem Cells Market Report (Status and Outlook)
    Published: 18-Aug-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed."The Mesenchymal Stem Cells market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Japan market, the top players include Lonza Thermo Fisher Bio-Techne Miltenyi Biotec PromoCell GmbH Irvine Scientific ......
  • 2017-2022 Malaysia Mesenchymal Stem Cells Market Report (Status and Outlook)
    Published: 18-Aug-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed."The Mesenchymal Stem Cells market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Malaysia market, the top players include Lonza Thermo Fisher Bio-Techne Miltenyi Biotec PromoCell GmbH Irvine Scientific......
  • 2017-2022 Philippines Mesenchymal Stem Cells Market Report (Status and Outlook)
    Published: 18-Aug-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed."The Mesenchymal Stem Cells market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In Philippines market, the top players include Lonza Thermo Fisher Bio-Techne Miltenyi Biotec PromoCell GmbH Irvine Scientif......
  • 2017-2022 United States Mesenchymal Stem Cells Market Report (Status and Outlook)
    Published: 18-Aug-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed."The Mesenchymal Stem Cells market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.In United States market, the top players include Lonza Thermo Fisher Bio-Techne Miltenyi Biotec PromoCell GmbH Irvine Scie......
  • Europe Mesenchymal Stem Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 15-Aug-2017        Price: US 4480 Onwards        Pages: 115
    Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. Scope of the Report: This report focuses on the Mesenchymal Stem Cells in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs